News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

News

November 10, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on November 2, 2022, entitled, “MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway.” continue reading »

Oncotarget | Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

News

November 9, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on November 2, 2022, entitled, “Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.” continue reading »

Aging | Lamin A to Z in normal aging

Aging

November 9, 2022
PRESS RELEASE: A new research perspective was published in Aging's Volume 14, Issue 20, entitled, “Lamin A to Z in normal aging.” continue reading »

Aging’s Scientific Integrity Process

Aging

November 8, 2022
The open-access journal Aging recently launched a new webpage showcasing the full Aging Scientific Integrity Process. continue reading »

Oncotarget | Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

News

November 8, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on November 2, 2022, entitled, “Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer.” continue reading »